Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Schechter

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
BMJ Supportive & Palliative Care|December 30, 2023
Yoga versus iPad active control for fatigue in paediatric cancer therapy: a randomised controlled trialTal Schechter, Cassandra Tardif-Theriault, Nicole Culos-Reed, et al.
Pediatric Transplantation|November 13, 2018
Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationSalah Ali, Sami AlThubaiti, Samuele Renzi, et al.
Pediatric Transplantation|July 7, 2015
The yield of monitoring for HSV and VZV viremia in pediatric hematopoietic stem cell transplant patientsKatharine Patrick, Muhammad Ali, Susan E Richardson, et al.
Cancer Medicine|June 23, 2020
Discordance between pediatric self-report and parent proxy-report symptom scores and creation of a dyad symptom screening tool (co-SSPedi)Deborah Tomlinson, Erin Plenert, Grace Dadzie, et al.
American Journal of Obstetrics and Gynecology|September 13, 2011
Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopicLaila Nurmohamed, Myla E Moretti, Tal Schechter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2019
Feasibility of a randomized controlled trial of symptom screening and feedback to healthcare providers compared with standard of care using the SPARK platformSadie Cook, Emily Vettese, George A Tomlinson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2019
Symptom documentation and intervention provision for symptom control in children receiving cancer treatmentsShannon Hyslop, Hailey Davis, Nathan Duong, et al.
BMC Cancer|September 26, 2020
Development of the SPARK family member web pages to improve symptom management for pediatric patients receiving cancer treatmentsCody Z Watling, Clodagh McCarthy, Alexandra Theodorakidis, et al.
Transplantation and Cellular Therapy|November 28, 2021
Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center AnalysisAnand Srinivasan, Enass Raffa, Donna A Wall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
IV busulfan dose individualization in children undergoing hematopoietic stem cell transplant: limited sampling strategiesL Lee Dupuis, Cathryn Sibbald, Tal Schechter, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
BMJ Supportive & Palliative Care|December 30, 2023
Yoga versus iPad active control for fatigue in paediatric cancer therapy: a randomised controlled trialTal Schechter, Cassandra Tardif-Theriault, Nicole Culos-Reed, et al.
Pediatric Transplantation|November 13, 2018
Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationSalah Ali, Sami AlThubaiti, Samuele Renzi, et al.
Pediatric Transplantation|July 7, 2015
The yield of monitoring for HSV and VZV viremia in pediatric hematopoietic stem cell transplant patientsKatharine Patrick, Muhammad Ali, Susan E Richardson, et al.
Cancer Medicine|June 23, 2020
Discordance between pediatric self-report and parent proxy-report symptom scores and creation of a dyad symptom screening tool (co-SSPedi)Deborah Tomlinson, Erin Plenert, Grace Dadzie, et al.
American Journal of Obstetrics and Gynecology|September 13, 2011
Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopicLaila Nurmohamed, Myla E Moretti, Tal Schechter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2019
Feasibility of a randomized controlled trial of symptom screening and feedback to healthcare providers compared with standard of care using the SPARK platformSadie Cook, Emily Vettese, George A Tomlinson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2019
Symptom documentation and intervention provision for symptom control in children receiving cancer treatmentsShannon Hyslop, Hailey Davis, Nathan Duong, et al.
BMC Cancer|September 26, 2020
Development of the SPARK family member web pages to improve symptom management for pediatric patients receiving cancer treatmentsCody Z Watling, Clodagh McCarthy, Alexandra Theodorakidis, et al.
Transplantation and Cellular Therapy|November 28, 2021
Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center AnalysisAnand Srinivasan, Enass Raffa, Donna A Wall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
IV busulfan dose individualization in children undergoing hematopoietic stem cell transplant: limited sampling strategiesL Lee Dupuis, Cathryn Sibbald, Tal Schechter, et al.
Pageof 15